Title

Dose-dependent in vivo effect of Rhodiola and Echinacea on the mitogen-induced lymphocyte proliferation in mice

Journal title

Polish Journal of Veterinary Sciences

Yearbook

2011

Issue

No 2

Authors

Dąbrowski, M. ; Skopińska-Różewska, E. ; Sokolnicka, I. ; Siwicki, A. ; Stankiewicz, W. ; Buchwald, W. ; Krajewska-Patan, A. ; Mielcarek, S. ; Mścisz, A. ; Furmanowa, M.

Divisions of PAS

Nauki Biologiczne i Rolnicze

Publisher

Polish Academy of Sciences Committee of Veterinary Sciences ; University of Warmia and Mazury in Olsztyn

Date

2011

Identifier

DOI: 10.2478/v10181-011-0040-9 ; ISSN 1505-1773

Source

Polish Journal of Veterinary Sciences; 2011; No 2

References

J Bany (2003), Echinacea purpurea stimulates cellular immunity and anti-bacterial defence independently of the strain of mice, Pol J Vet Sci, 6, Suppl, 3. ; J Blomkvist (2009), Perspective on Roseroot (Rhodiola rosea) studies, Planta Med, 75, 1187, doi.org/10.1055/s-0029-1185720 ; R Burger (1997), Echinacea-induced cytokine production by human macrophages, Int J Immunopharmacol, 19, 371, doi.org/10.1016/S0192-0561(97)00061-1 ; L Clifford (2002), Bioactivity of alkamides isolated from Echinacea purpurea (L) Moench, Phytomedicine, 9, 249, doi.org/10.1078/0944-7113-00105 ; M Dąbrowski (2001), Competition of IL-1 and IL-1ra determines lymphocyte response to delayed stimulation with PHA, Mediators Inflamm, 10, 101. ; G Dong (2006), Immuno-suppressive effect of blocking the CD28 signaling pathway in T-cells by an active component of Echinacea found by a novel pharmaceutical screening method, J Med Chem, 49, 1845, doi.org/10.1021/jm0509039 ; G Dong (2009), Blocking effect of an immune-suppressive agent, cynarin, on CD28 of T-cell receptor, Pharm Res, 26, 375, doi.org/10.1007/s11095-008-9754-5 ; EMEA (<b>2000</b>) <a target="_blank" href='http://www.eudra.org/emea.html'>http://www.eudra.org/emea.html</a> ; E Ernst (2002), The risk-benefit profile of commonly used herbal therapies: Gingko, St. John's Wort, Ginseng, Echinacea, Saw Palmetto, and Kava, Ann Intern Med, 136, 42. ; M Furmanowa (1988), Rhodiola rosea in vitro culture-phytochemical analysis and anti-oxidant action, Acta Societ Botanic Poloniae, 6, 69. ; M Furmanowa (1999), Phytochemical and pharmacological properties of Rhodiola rosea L, Herba Polonica, 45, 108. ; J Gertsch (2004), Echinacea alkylamides modulate TNF-alpha gene expression via cannabinoid receptor CB2 and multiple signal transduction pathways, FEBS Lett, 577, 563, doi.org/10.1016/j.febslet.2004.10.064 ; H Hallgren (1977), Suppressor lymphocytes in young and aged humans, J Immunol, 118, 2004. ; K Hostettmann (2003), History of a plant: the example of Echinacea, Forsch Komplementarmed Klass Naturheilkd, 10, 1, 9. ; S Hung (2011), The effectiveness and efficacy of Rhodiola rosea L.: A systematic review of randomized clinical trials, Phytomedicine, 18, 235, doi.org/10.1016/j.phymed.2010.08.014 ; H Jeong (2009), Neuraminidase inhibitory activities of flavonols isolated from Rhodiola rosea roots and their in vitro anti-influenza viral activities, Bioorg Med Chem, 17, 6816, doi.org/10.1016/j.bmc.2009.08.036 ; G Joksic (2009), Biological effects of Echinacea purpurea on human blood cells, Art Hig Rada Toksikol, 60, 165. ; J Kim (2005), Risks of the complementary medicine Rhodiola rosea in breast cancer, J Nutrition (suppl), 135, 3048. ; H Kovaru (2010), Effect of mitogen lectin on lymphocyte or brain cortex cell activation, Neuro Endocrinol Lett, 31, 325. ; S Mielcarek (2005), Phytochemical investigation of Rhodiola sp. Root extracts, Herba Polonica, 51, 1, 159. ; E Mierzwińska-Nastalska (2005), The effect of Echinacea purpurea extract "Echinapur" on the angiogenic and chemokinetic activity of human leukocytes, Pol J Environm Studies, 14, 2, 639. ; B Min (1999), Screening of Korean plants against human immunodeficiency virus (HIV-1) protease, Phytother Res, 13, 680, doi.org/10.1002/(SICI)1099-1573(199912)13:8<680::AID-PTR501>3.0.CO;2-H ; D Ming (2005), Bioactive compounds from Rhodiola rosea (Crassulaceae), Phytother Res, 19, 740, doi.org/10.1002/ptr.1597 ; P Neveu (1986), Modulation of mitogen-induced lymphoproliferation by cerebral neocortex, Life Sci, 38, 1907, doi.org/10.1016/0024-3205(86)90219-5 ; W O'Neill (2002), Immunological and haematinic consequences of feeding a standardized Echinacea (Echinacea angustifolia) extract to healthy horses, Equine Vet J, 34, 222, doi.org/10.2746/042516402776186001 ; A Panossian (2010), (Rosenroot (Rhodiola rosea): traditional use, chemical composition, pharmacology and clinical efficacy, Phytomedicine, 17, 481, doi.org/10.1016/j.phymed.2010.02.002 ; L Pecanha (1989), Murine polyclonal T-lymphocyte activation induced by phytohemagglutinin; differential lymphokine requirements of two unusual activation pathways defined by resistance to blockade by barium and by cyclosporine A, Int J Immunopharmacol, 11, 149, doi.org/10.1016/0192-0561(89)90066-0 ; R Reinke (2004), L-chicoric acid inhibits human immunodeficiency virus (HIV-1) integration in vivo and is a noncompetitive but reversible inhibitor of HIV-1 integrase in vitro, Virology, 326, 203, doi.org/10.1016/j.virol.2004.06.005 ; W Robinson Jr (1998), L-chicoric acid, an inhibitor of human immunodeficiency virus (HIV-1) integrase, improves on the in vitro anti-HIV-1 effect of Zidovudine plus a protease inhibitor (AG1350), Antiviral Res, 39, 101, doi.org/10.1016/S0166-3542(98)00037-0 ; E Rogala (2008), Echinacea purpurea diminishes neovascular reaction induced in mice skin by human cancer cells and stimulates non-specific cellular immunity in humans, Centr Eur J Immunol, 33, 127. ; D See (1997), In vitro effects of Echinacea and Ginseng on natural killer and antibody-dependent cell cytotoxicity in healthy subjects and chronic fatigue syndrome or acquired immunodeficiency syndrome patients, Immunopharmacology, 35, 229, doi.org/10.1016/S0162-3109(96)00125-7 ; B Sloley (2001), Comparison of chemical components and antioxidant capacity of different Echinacea species, J Pharm Pharmacol, 53, 849, doi.org/10.1211/0022357011776009 ; A Siwicki (2007), The influence of Rhodiola rosea extracts on non-specific and specific cellular immunity in pigs, rats and mice, Centr Eur J Immunol, 32, 84. ; E Skopińska-Różewska (2002), Wpływ substancji naturalnych na układ odpornościowy. Wydawnictwo, 32. ; E Skopińska-Różewska (2003), The in vivo effect of Echinacea purpurea succus on various functions of human blood leukocytes, Centr Eur J Immunol, 28, 126. ; E Skopińska-Różewska (2008a), The effect of Rhodiola quadrifida extracts on cellular immunity in mice and rats, Pol J Vet Sci, 11, 105. ; E Skopinska-Rozewska (2008b), Aqueous and hydro-alcoholic extracts of Echinacea purpurea (L) Moench as traditional herbal remedies with immunotropic activity, Centr Eur J Immunol, 33, 78. ; E Skopińska-Różewska (2009), The in vivo effect of Rhodiola rosea and Rhodiola quadrifida hydro-alcoholic extracts on chemokinetic activity of spleen lymphocytes in mice, Centr Eur J Immunol, 34, 42. ; E Skopińska-Różewska (2010), The In vivo effect of dry hydro-alcoholic extract of Echinacea purpurea on angiogenic activity of human blood mononuclear cells, Centr Eur J Immunol, 35, 223. ; K Spelman (2009), Role for PPARgamma in IL-2 inhibition in T cells by Echinacea-derived undeca - 2E-ene-8,10-diynoic acid isobutylamide, Int Immunopharmacol, 9, 1260, doi.org/10.1016/j.intimp.2009.08.009 ; R Tsien (1982), T-cell mitogens cause early changes in cytoplasmic free Ca2+ and membrane potential in lymphocytes, Nature, 295, 68, doi.org/10.1038/295068a0 ; T Wang (1978), Rise and fall of cAMP required for onset of lymphocyte DNA synthesis, Science, 201, 155, doi.org/10.1126/science.208147 ; H Wiedenfeld (2007), Phytochemical and analytical studies of extracts from Rhodiola rosea and Rhodiola quadrifida, Pharmazie, 62, 308. ; R Wójcik (2009a), The In vitro influence of Rhodiola kirilowii extracts on blood granulocytes potential killing activity (PKA) in pigs, Centr Eur J Immunol, 34, 158. ; R Wójcik (2009b), The In vitro effect of Rhodiola quadrifida and Rhodiola kirilowii extracts on pigs blood lymphocyte response to mitogen Concanavalin A, Centr Eur J Immunol, 34, 166.